| Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement … H Amital, Z Szekanecz, G Szücs, K Danko, E Nagy, T Csépány, E Kiss, ... Annals of the rheumatic diseases 69 (6), 1155-1157, 2010 | 393 | 2010 |
| Novel biomarkers in autoimmune diseases H Orbach, G ZANDMAN‐GODDARD, H AMITAL, V Barak, Z Szekanecz, ... Annals of the New York Academy of Sciences 1109 (1), 385-400, 2007 | 331 | 2007 |
| Sequence specificity of mRNA N6-adenosine methyltransferase. T Csepany, A Lin, CJ Baldick Jr, K Beemon Journal of Biological Chemistry 265 (33), 20117-20122, 1990 | 200 | 1990 |
| Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ... Annals of Neurology 77 (3), 425-435, 2015 | 186 | 2015 |
| Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study T Kalincik, JWL Brown, N Robertson, M Willis, N Scolding, CM Rice, ... The Lancet Neurology 16 (4), 271-281, 2017 | 171 | 2017 |
| The 11-year long-term follow-up study from the randomized BENEFIT CIS trial L Kappos, G Edan, MS Freedman, X Montalban, HP Hartung, B Hemmer, ... Neurology 87 (10), 978-987, 2016 | 145 | 2016 |
| Risk of secondary progressive multiple sclerosis: a longitudinal study A Fambiatos, V Jokubaitis, D Horakova, E Kubala Havrdova, M Trojano, ... Multiple Sclerosis Journal 26 (1), 79-90, 2020 | 78 | 2020 |
| Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years T Kalincik, I Diouf, S Sharmin, C Malpas, T Spelman, D Horakova, ... Neurology 96 (5), e783-e797, 2021 | 73 | 2021 |
| MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension T Csépány, D Bereczki, J Kollár, J Sikula, E Kiss, L Csiba Journal of neurology 250, 1348-1354, 2003 | 73 | 2003 |
| Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system M Banati, P Csecsei, E Koszegi, HH Nielsen, G Suto, L Bors, A Trauninger, ... European journal of neurology 20 (11), 1492-1495, 2013 | 71 | 2013 |
| Ferritin and prolactin levels in multiple sclerosis R Da Costa, M Szyper-Kravitz, Z Szekanecz, T Csépány, K Dankó, ... IMAJ-Israel Medical Association Journal 13 (2), 91, 2011 | 59 | 2011 |
| The Debrecen Stroke Database: demographic characteristics, risk factors, stroke severity and outcome in 8088 consecutive hospitalised patients with acute cerebrovascular disease D Bereczki, L Mihálka, I Fekete, A Valikovics, T Csépány, B Fülesdi, ... International Journal of Stroke 4 (5), 335-339, 2009 | 46 | 2009 |
| Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder A Kunchok, C Malpas, P Nytrova, EK Havrdova, R Alroughani, M Terzi, ... Multiple sclerosis and related disorders 38, 101868, 2020 | 40 | 2020 |
| The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple … Z Fricska-Nagy, J Füvesi, C Rózsa, S Komoly, G Jakab, T Csépány, ... Multiple sclerosis and related disorders 7, 26-32, 2016 | 37 | 2016 |
| Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression E De Brouwer, T Becker, Y Moreau, EK Havrdova, M Trojano, S Eichau, ... Computer methods and programs in biomedicine 208, 106180, 2021 | 33 | 2021 |
| Potassium channel expression in human CD4+ regulatory and naive T cells from healthy subjects and multiple sclerosis patients Z Varga, T Csepany, F Papp, A Fabian, P Gogolak, A Toth, G Panyi Immunology letters 124 (2), 95-101, 2009 | 33 | 2009 |
| Basic characteristics of hospital stroke services in Eastern Hungary L Mihálka, I Fekete, T Csépány, L Csiba, D Bereczki European journal of epidemiology 15, 461-466, 1999 | 32 | 1999 |
| Delay from treatment start to full effect of immunotherapies for multiple sclerosis I Roos, E Leray, F Frascoli, R Casey, JWL Brown, D Horakova, ... Brain 143 (9), 2742-2756, 2020 | 30 | 2020 |
| Epidemiology of familial multiple sclerosis in Hungary Z Fricska-Nagy, K Bencsik, C Rajda, J Füvesi, V Honti, T Csepany, ... Multiple Sclerosis Journal 13 (2), 260-261, 2007 | 28 | 2007 |
| Abnormal Cell‐Specific Expressions of Certain Protein Kinase C Isoenzymes in Peripheral Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect of … T Bíró, Z Griger, E Kiss, H Papp, M Aleksza, I Kovács, M Zeher, E Bodolay, ... Scandinavian journal of immunology 60 (4), 421-428, 2004 | 27 | 2004 |
